Gregory J. Flesher

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

OKUR

Current role

Board Member

ELDN

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	OnKure Therapeutics, Inc. (OKUR)	Former President and Chief Executive Officer	$453,365	—	—	—	—	$1,326,242	$1,779,607
2023	OnKure Therapeutics, Inc. (OKUR)	Former President and Chief Executive Officer	$563,942	—	—	—	—	$5,762	$569,704
2022	OnKure Therapeutics, Inc. (OKUR)	President and Chief Executive Officer	$545,000	—	—	$393,000	$245,300	$10,152	$1,193,452
2021	OnKure Therapeutics, Inc. (OKUR)	President and Chief Executive Officer	$475,000	—	$429,699	$4,196,725	$219,700	$48,346	$5,369,470
2020	OnKure Therapeutics, Inc. (OKUR)	Chief Executive Officer and President Vineet R. Jindal\	$79,167	—	—	—	$39,600	$14,180	$132,947
2020	Eledon Pharmaceuticals, Inc. (ELDN)	Former Chief Executive Officer Catherine C. Turkel^(^^5)^	$364,496	$121,669	—	$611,826	—	$1,317,595	$2,415,586
2019	Eledon Pharmaceuticals, Inc. (ELDN)	Former Chief Executive Officer Catherine C. Turkel^(^^5)^	$480,436	—	$66,847	$293,683	—	$1,698	$842,664
2018	Eledon Pharmaceuticals, Inc. (ELDN)	Chief Executive Officer	$459,865	—	$99,255	$191,327	$191,194	$1,440	$943,081

Earnings-call appearances and filed executive appointments or departures, newest first.